Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arrigo Schieppati

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 4, 2016
Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in EuropeJulio López-Bastida, Renata Linertová, Juan Oliva-Moreno, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 14, 2016
Social/economic costs and health-related quality of life in patients with fragile X syndrome in EuropeKarine Chevreul, Coralie Gandré, Karen Berg Brigham, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 5, 2016
Social/economic costs and health-related quality of life in patients with histiocytosis in EuropeGeorgi Iskrov, Itziar Astigarraga, Rumen Stefanov, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 10, 2016
Social/economic costs and health-related quality of life in patients with cystic fibrosis in EuropeKarine Chevreul, Morgane Michel, Karen Berg Brigham, et al.
Health Policy (Amsterdam, Netherlands)|September 6, 2012
Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD studyRenata Linertová, Pedro Serrano-Aguilar, Manuel Posada-de-la-Paz, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 4, 2016
Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in EuropeMarianna Cavazza, Yllka Kodra, Patrizio Armeni, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 7, 2016
Social/economic costs and quality of life in patients with haemophilia in EuropeMarianna Cavazza, Yllka Kodra, Patrizio Armeni, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 11, 2016
Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in EuropeMárta Péntek, László Gulácsi, Valentin Brodszky, et al.
Kidney International. Supplement|August 20, 2005
Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 DeclarationJohn H Dirks, Dick de Zeeuw, Sanjay K Agarwal, et al.
Trials|March 29, 2012
Typical investigational medicinal products follow relatively uniform regulations in 10 European Clinical Research Infrastructures Network (ECRIN) countriesChristian Gluud, Christine Kubiak, Kate Whitfield, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 4, 2016
Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in EuropeJulio López-Bastida, Renata Linertová, Juan Oliva-Moreno, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 14, 2016
Social/economic costs and health-related quality of life in patients with fragile X syndrome in EuropeKarine Chevreul, Coralie Gandré, Karen Berg Brigham, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 5, 2016
Social/economic costs and health-related quality of life in patients with histiocytosis in EuropeGeorgi Iskrov, Itziar Astigarraga, Rumen Stefanov, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 10, 2016
Social/economic costs and health-related quality of life in patients with cystic fibrosis in EuropeKarine Chevreul, Morgane Michel, Karen Berg Brigham, et al.
Health Policy (Amsterdam, Netherlands)|September 6, 2012
Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD studyRenata Linertová, Pedro Serrano-Aguilar, Manuel Posada-de-la-Paz, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 4, 2016
Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in EuropeMarianna Cavazza, Yllka Kodra, Patrizio Armeni, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 7, 2016
Social/economic costs and quality of life in patients with haemophilia in EuropeMarianna Cavazza, Yllka Kodra, Patrizio Armeni, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 11, 2016
Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in EuropeMárta Péntek, László Gulácsi, Valentin Brodszky, et al.
Kidney International. Supplement|August 20, 2005
Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 DeclarationJohn H Dirks, Dick de Zeeuw, Sanjay K Agarwal, et al.
Trials|March 29, 2012
Typical investigational medicinal products follow relatively uniform regulations in 10 European Clinical Research Infrastructures Network (ECRIN) countriesChristian Gluud, Christine Kubiak, Kate Whitfield, et al.
Pageof 6